You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart

Article: Therapy-related myeloid neoplasms: epidemiology, pathogenesis and therapeutic options

€3.03

SKU: product-article-33010 Category: General

Description
Reviews (0)

Description

Therapy-related myeloid neoplasms: epidemiology, pathogenesis and therapeutic options

Reviews

There are no reviews yet.

Be the first to review “Article: Therapy-related myeloid neoplasms: epidemiology, pathogenesis and therapeutic options”

You must be logged in to post a review.

Top

Article: Therapy-related myeloid neoplasms: epidemiology, pathogenesis and therapeutic options

Description

Reviews

Related products

Article: Highlights in respiratory oncology

Article: Highlights in urologic cancer

Article: Highlights in melanoma

Article: Highlights in squamous cell carcinoma of the head and neck